AI assistant
Elevance Health, Inc. — Director's Dealing 2021
Mar 3, 2021
29933_dirs_2021-03-03_6573c81c-cce5-45b6-9eb6-8bc281d1ccb5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Anthem, Inc. (ANTM)
CIK: 0001156039
Period of Report: 2021-03-01
Reporting Person: BOUDREAUX GAIL (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-03-01 | Common Stock | F | 35564 | $311.48 | Disposed | 18109 | Direct |
| 2021-03-01 | Common Stock | A | 10595 | — | Acquired | 28704 | Direct |
| 2021-03-01 | Common Stock | A | 73240 | — | Acquired | 101944 | Direct |
| 2021-03-02 | Common Stock | F | 1644 | $311.66 | Disposed | 100300 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-03-01 | Employee Stock Option (Right to Buy) | $311.48 | A | 43501 | Acquired | 2031-03-01 | Common Stock (43501.0) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 60 | Indirect |
Footnotes
F1: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
F2: Represents restricted share units. Restrictions lapse as follows: 3,531 shares on 3/1/2022, and 3,532 shares each on 3/1/2023 and 3/1/2024.
F3: Represents performance based restricted share units. Restrictions lapse on 3/1/2021.
F4: Balance includes 78.8 shares acquired on December 22, 2020 through a dividend reinvestment plan.
F5: The option represents a right to purchase a total of 43,501 shares, and is exercisable in three annual installments, with two installments of 14,500 shares each and one installment of 14,501 shares, beginning on 3/1/2022, which is the one-year anniversary of the option grant date.